|Day Low/High||3.98 / 4.33|
|52 Wk Low/High||4.01 / 26.73|
Here's how to trade some of the most active stocks on the market right now.
Stocks get pummeled Wednesday after investors lose confidence amid a confluence of economic and geopolitical factors.
U.S. stock markets are sinking Wednesday afternoon as the new quarter begins with a barrage of weak overseas and domestic data, coupled with troubles brewing in China.
Shares of Tekmira Pharmaceuticals (TKMR) surged in morning trading Wednesday after the CDC confirmed the first U.S. Ebola case in Dallas.
U.S. stocks sink Wednesday as geopolitical jitters flare and investors await a stronger confirmation of market fundamentals.
Ebola lands in Texas, so expect some crazy volatility Wednesday in biotech and drug stocks.
U.S. stock futures slip Wednesday ahead of job and manufacturing reports and amid the U.S's unprecedented diagnoses of the Ebola virus.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a pre-market mover with heavy volume candidate
U.S. stock futures are flat to slightly lower; Tekmira shares soar as first Ebola case is diagnosed in the U.S.; Amazon and Disney close to settling DVD dispute.
The trading panel discussed what the first U.S. case of Ebola means to drug companies and whether to gamble on casinos.
Tekmira Pharmaceuticals (TKMR) shares are climbing following the news that the first case of Ebola has been confirmed in the U.S.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a post-market leader candidate
Cramer is no fan of Annaly Capital but does like Opko Health and Dow Chemical.
Lighten up on your holdings the next time the market soars so you can buy them back at lower prices during the next inevitable selloff, Cramer advises.
Biotech columnist Adam Feuerstein answers readers' questions about health care.
The trading panel discussed whether the Alibaba IPO is affecting the markets and whether Apple shares will decline.
Ebola patient Dr. Rick Sacra received treatment with Tekmira Pharmaceuticals' experimental ebola therapy TKM-Ebola for seven days, Nebraska Medical Center confirmed.
Tekmira Pharmaceuticals (TKMR) shares are up double digits after the company announced that it received regulatory approval to administer its Ebola treatment.
Twitter abuzz with speculation that Tekmira's experimental Ebola therapy is being used to treat patient.
The Ebola outbreak in West Africa is a public health emergency which has also captured the attention of U.S. investors (perhaps I should say traders.)
Cramer likes Take-Two Interactive over Activision Blizzard and if you wanted Tekmira Pharmaceuticals you're too late.
Cramer is looking for bargains, and that means he'll be watching Yahoo!, Apple and Restoration Hardware next week.
Trade-Ideas LLC identified Tekmira Pharmaceuticals (TKMR) as a post-market laggard candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.